HEMOSTASIS COAGULATION ROUTINE REAGENTS INHIBITOR NIJMEGEN BETHESDA ASSAYS FVIII INHIBITOR NIJMEGEN BETHESDA ASSAYS
Factor VIII Inhibitor Reagent Kit (Bethesda Units)
This kit, intended for use in the clinical laboratory, is used to standardize the preparation of samples for the assay of inhibitors by the modified Bethesda Nijmegen method.
Intended for use in the clinical laboratory when performing the modified Bethesda or Besthesda Nijmegen assay.
Informations
Treatment for hemophilia A consists of injecting the missing Factor VIII by I.V. to prevent or stop the bleeding. A majority of the complications of this treatment are the development of antibodies against FVIII, called inhibitors.
The development of an anti-FVIII inhibitor leads to episodes of bleeding that are difficult to control.
The activity of the inhibitor is measured by a Bethesda test and is expressed in BU.
1BU neutralizes 50% of the activity of FVIII for hemophilia A.
Documentation
Download the product sheetPrice list, safety data sheets and notices are accessible to our registered customers.
Nijmegen Bethesda Assay
References
| 4-5152005 | Kit | 2 to 4 tests |
